SCHEMBL4924159

SCHEMBL4924159

O=C(O)CNC(=O)c1cc(Br)c(OCc2cc(Cl)cc(NC3CCC3)c2F)c(Br)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 1/20 0.36
PDE4B Q07343 1/20 0.36
PDE4C Q08493 1/20 0.36
PDE4D Q08499 1/20 0.36
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
DDR1 Q08345 1/20 0.32
SMN1; SMN2 Q16637 4/20 0.32
MAPT P10636 1/20 0.31
RAB9A P51151 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
TAOK1 Q7L7X3 1/20 0.31
TAOK3 Q9H2K8 1/20 0.31
DHODH Q02127 1/20 0.31
ACLY P53396 1/20 0.31
F10 P00742 1/20 0.31
LMNA P02545 2/20 0.31
ALDH1A1 P00352 1/20 0.31
GAA P10253 1/20 0.31
HPGD P15428 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4933959 0.92 PDE4A (0.36) PDE4APDE4BPDE4CPDE4DMEN1
SCHEMBL4361512 0.91 PDE4A (0.37) PDE4APDE4BPDE4CPDE4DMEN1
SCHEMBL4931827 0.90 PDE4A (0.37) PDE4APDE4BPDE4CPDE4DMEN1
SCHEMBL4923995 0.87 PDE4A (0.38) PDE4APDE4BPDE4CPDE4DMEN1
SCHEMBL5717783 0.87 PTGDR (0.34) PDE4APDE4BPDE4CPDE4DMEN1
SCHEMBL5717776 0.86 PDE4A (0.36) PDE4APDE4BPDE4CPDE4DMEN1
SCHEMBL4934502 0.85 GPR139 (0.37) MEN1KMT2ASMN1; SMN2MAPTRAB9A
SCHEMBL4934616 0.85 CACNA1I (0.35) ACLYF10
SCHEMBL4933377 0.85 THRB (0.47) MEN1KMT2AACLYTHRATHRB
SCHEMBL4922427 0.84 SMN1; SMN2 (0.36) MEN1KMT2ASMN1; SMN2MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080221210-A1 Thyroid Receptor Agonists KARO BIO AB (SE) 2008-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080221210-A1 Thyroid Receptor Agonists TSHR, TRHR, THRA PDE4A 897/4885PDE4B 1391/4885PDE4C 1556/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.